Agent BZ (3-quinuclidinyl benzilate) is a centrally acting synthetic anticholinergic agent, considered as a potential military incapacitating chemical warfare agent. Despite its significance as a model compound in pharmacological research and its potential misuse in chemical attacks, few modern analytical methods for BZ determination in biological samples have been published. The goal of the present work is to develop and validate a sensitive and rapid LC-MS/MS method for the determination of agent BZ in rat plasma. The sample preparation was based on solid-phase extraction on C-18 cartridges. The reversed-phase HPLC coupled with the mass spectrometer with electrospray ionization in the positive ion-selective reaction monitoring mode was employed in the BZ analysis. Atropine was used as an internal standard. The presented method is selective, accurate, precise, and linear (r2 = 0.9947) in a concentration range from 0.5 ng/mL to 1 000 ng/mL and sensitive enough (limit of detection 0.2 ng/mL; limit of quantification 0.5 ng/mL) to determine the BZ plasma levels in rats exposed to 2 mg/kg and 10 mg/kg of BZ. The highest level of BZ in plasma was observed 5 minutes after intramuscular administration (154.6 ± 22.3 ng/mL in rats exposed to 2 mg/kg of BZ and 1024 ± 269 ng/mL in rats exposed to 10 mg/kg). After 48 h, no BZ was observed at detectable levels. This new method allows the detection and quantification of BZ in biological samples after exposure of an observed organism and it will be further optimized for other tissues to observe the distribution of BZ in organs.

Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Charles University Faculty of Pharmacy in Hradec Kralove Czech Republic

Department of Toxicology and Military Pharmacy University of Defense Faculty of Military Health Sciences Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc20028301

003      

CZ-PrNML

005      

20210114153449.0

007      

ta

008      

210105s2020 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1002/dta.2742 $2 doi

035    __

$a (PubMed)31785126

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Herman, David $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

245    10

$a Simple validated method of LC-MS/MS determination of BZ agent in rat plasma samples / $c D. Herman, A. Dlabkova, L. Cechova, N. Vanova, J. Misik, D. Jun, J. Zdarova Karasova,

520    9_

$a Agent BZ (3-quinuclidinyl benzilate) is a centrally acting synthetic anticholinergic agent, considered as a potential military incapacitating chemical warfare agent. Despite its significance as a model compound in pharmacological research and its potential misuse in chemical attacks, few modern analytical methods for BZ determination in biological samples have been published. The goal of the present work is to develop and validate a sensitive and rapid LC-MS/MS method for the determination of agent BZ in rat plasma. The sample preparation was based on solid-phase extraction on C-18 cartridges. The reversed-phase HPLC coupled with the mass spectrometer with electrospray ionization in the positive ion-selective reaction monitoring mode was employed in the BZ analysis. Atropine was used as an internal standard. The presented method is selective, accurate, precise, and linear (r2 = 0.9947) in a concentration range from 0.5 ng/mL to 1 000 ng/mL and sensitive enough (limit of detection 0.2 ng/mL; limit of quantification 0.5 ng/mL) to determine the BZ plasma levels in rats exposed to 2 mg/kg and 10 mg/kg of BZ. The highest level of BZ in plasma was observed 5 minutes after intramuscular administration (154.6 ± 22.3 ng/mL in rats exposed to 2 mg/kg of BZ and 1024 ± 269 ng/mL in rats exposed to 10 mg/kg). After 48 h, no BZ was observed at detectable levels. This new method allows the detection and quantification of BZ in biological samples after exposure of an observed organism and it will be further optimized for other tissues to observe the distribution of BZ in organs.

650    _2

$a zvířata $7 D000818

650    _2

$a cholinergní antagonisté $x analýza $x krev $7 D018680

650    _2

$a vysokoúčinná kapalinová chromatografie $7 D002851

650    _2

$a limita detekce $7 D057230

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a chinuklidinylbenzilát $x analýza $x krev $7 D011813

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani Wistar $7 D017208

650    _2

$a hmotnostní spektrometrie s elektrosprejovou ionizací $7 D021241

650    _2

$a tandemová hmotnostní spektrometrie $7 D053719

655    _2

$a časopisecké články $7 D016428

655    _2

$a validační studie $7 D023361

700    1_

$a Dlabkova, Alzbeta $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

700    1_

$a Cechova, Lenka $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

700    1_

$a Vanova, Nela $u Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Charles University Faculty of Pharmacy in Hradec Kralove, Czech Republic.

700    1_

$a Misik, Jan $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

700    1_

$a Jun, Daniel $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

700    1_

$a Zdarova Karasova, Jana $u Department of Toxicology and Military Pharmacy, University of Defense Faculty of Military Health Sciences, Czech Republic.

773    0_

$w MED00188061 $t Drug testing and analysis $x 1942-7611 $g Roč. 12, č. 4 (2020), s. 431-438

856    41

$u https://pubmed.ncbi.nlm.nih.gov/31785126 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20210114153447 $b ABA008

999    __

$a ok $b bmc $g 1608636 $s 1119481

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 12 $c 4 $d 431-438 $e 20200110 $i 1942-7611 $m Drug testing and analysis $n Drug Test Anal $x MED00188061

GRA    __

$a 1011 $p Ministry of Defence of the Czech Republic, Long-term organization development plan

GRA    __

$a SV/FVZ201505 $p Ministry of Education, Youth and Sports of the Czech Republic

LZP    __

$a Pubmed-20210105